Targeted inhibition of activin receptor-like kinase 5 signaling attenuates cardiac dysfunction following myocardial infarction

被引:93
|
作者
Tan, Sih Min [1 ]
Zhang, Yuan [1 ]
Connelly, Kim A. [1 ,3 ]
Gilbert, Richard E. [1 ,3 ]
Kelly, Darren J. [1 ,2 ]
机构
[1] Univ Melbourne, Dept Med, St Vincents Hosp, Fitzroy, Vic 3065, Australia
[2] St Vincents Inst Med Res, Melbourne, Vic, Australia
[3] Univ Toronto, St Michaels Hosp, Dept Med, Toronto, ON M5B 1W8, Canada
基金
英国医学研究理事会;
关键词
interstitial fibrosis; cardiac remodeling; heart failure; SMOOTH MUSCLE ACTIN; DIASTOLIC DYSFUNCTION; ANGIOTENSIN-II; FIBROSIS; TISSUE; INJURY; HEART; MYOFIBROBLASTS; HYPERTROPHY; TRANSITION;
D O I
10.1152/ajpheart.01048.2009
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Tan SM, Zhang Y, Connelly KA, Gilbert RE, Kelly DJ. Targeted inhibition of activin receptor-like kinase 5 signaling attenuates cardiac dysfunction following myocardial infarction. Am J Physiol Heart Circ Physiol 298: H1415-H1425, 2010. First published February 12, 2010; doi:10.1152/ajpheart.01048.2009.-Following myocardial infarction (MI), the heart undergoes a pathological process known as remodeling, which in many instances results in cardiac dysfunction and ultimately heart failure and death. Transforming growth factor-beta (TGF-beta) is a key mediator in the pathogenesis of cardiac remodeling following MI. We thus aimed to inhibit TGF-beta signaling using a novel orally active TGF-beta type I receptor [activin receptor-like kinase 5 (ALK5)] inhibitor (GW788388) to attenuate left ventricular remodeling and cardiac dysfunction in a rat model of MI. Sprague-Dawley rats underwent left anterior descending coronary artery ligation to induce experimental MI and then were randomized to receive GW788388 at a dosage of 50 mg . kg(-1) . day(-1) or vehicle 1 wk after surgery. After 4 wk of treatment, echocardiography was performed before the rats were euthanized. Animals that received left anterior descending coronary artery ligation demonstrated systolic dysfunction, Smad2 activation, myofibroblasts accumulation, collagen deposition, and myocyte hypertrophy (all P < 0.05). Treatment with GW788388 significantly attenuated systolic dysfunction in the MI animals, together with the attenuation of the activated (phosphorylated) Smad2 (P < 0.01), alpha-smooth muscle actin (P < 0.001), and collagen I (P < 0.05) in the noninfarct zone of MI rats. Cardiomyocyte hypertrophy in MI hearts was also attenuated by ALK5 inhibition (P < 0.05). In brief, treatment with a novel TGF-beta type I receptor inhibitor, GW788388, significantly reduced TGF-beta activity, leading to the attenuation of systolic dysfunction and left ventricular remodeling in an experimental rat model of MI.
引用
收藏
页码:H1415 / H1425
页数:11
相关论文
共 50 条
  • [31] Activin receptor-like kinase 7 silencing alleviates cardiomyocyte apoptosis, cardiac fibrosis and left ventricular dysfunction in type 2 diabetic rat
    Lin, Liu
    Zhong, Ming
    Li, Li
    Shang, Yuanyuan
    Wang, Zhihao
    Zhang, Yun
    Chen, Yuguo
    Zhang, Wei
    Tang, Mengxiong
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 64 (16) : C4 - C4
  • [32] DPP-4 Inhibition Attenuates Cardiac Dysfunction and Adverse Remodeling Following Myocardial Infarction in Rats with Experimental Diabetes
    Connelly, Kim Alexander
    Zhang, Yanling
    Advani, Andrew
    Advani, Suzanne L.
    Thai, Kerri
    Yuen, Darren A.
    Gilbert, Richard E.
    CARDIOVASCULAR THERAPEUTICS, 2013, 31 (05) : 259 - 267
  • [34] Activin receptor-like kinase 1 modulates transforming growth factor-β1 signaling in the regulation of angiogenesis
    Oh, SP
    Seki, T
    Goss, KA
    Imamura, T
    Yi, Y
    Donahoe, PK
    Li, L
    Miyazono, K
    ten Dijke, P
    Kim, S
    Li, E
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (06) : 2626 - 2631
  • [35] Specificity and Structure of a High Affinity Activin Receptor-like Kinase 1 (ALK1) Signaling Complex
    Townson, Sharon A.
    Martinez-Hackert, Erik
    Greppi, Chloe
    Lowden, Patricia
    Sako, Dianne
    Liu, June
    Ucran, Jeffrey A.
    Liharska, Katia
    Underwood, Kathryn W.
    Seehra, Jasbir
    Kumar, Ravindra
    Grinberg, Asya V.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2012, 287 (33) : 27313 - 27325
  • [36] Role and regulation of Nodal/Activin receptor-like kinase 7 signaling pathway in the control of ovarian follicular atresia
    Wang, Hongmei
    Jiang, Jin-Yi
    Zhu, Cheng
    Peng, Chun
    Tsang, Benjamin K.
    MOLECULAR ENDOCRINOLOGY, 2006, 20 (10) : 2469 - 2482
  • [37] Partial inhibition of activin receptor-like kinase 4 alleviates bladder fibrosis caused by bladder outlet obstruction
    Wang, Ning
    Lu, Lu
    Cao, Qi Feng
    Qian, Subo
    Ding, Jie
    Wang, Chen
    Duan, Huangqi
    Shen, Haibo
    Qi, Jun
    EXPERIMENTAL CELL RESEARCH, 2021, 406 (01)
  • [38] Activin receptor-like kinase 2 stimulates epithelial-mesenchymal transformation during cardiac valve formation
    Desgrosellier, J
    Mundell, N
    Barnett, JV
    FASEB JOURNAL, 2004, 18 (05): : A773 - A773
  • [39] Profibrogenic transforming growth Factor-β/Activin receptor-like kinase 5 signaling via connective tissue growth factor expression in hepatocytes
    Weng, Hong-Lei
    Ciuclan, Loredana
    Liu, Yan
    Hamzavi, Jafar
    Godoy, Patricio
    Gaitantzi, Haristi
    Kanzler, Stefan
    Heuchel, Rainer
    Ueberham, Uwe
    Gebhardt, Rolf
    Breitkopf, Katja
    Dooley, Steven
    HEPATOLOGY, 2007, 46 (04) : 1257 - 1270
  • [40] Inhibition of activin-like kinase 4/5 attenuates cancer cachexia associated muscle wasting
    Levolger, S.
    Wiemer, E. A. C.
    van Vugt, J. L. A.
    Huisman, S. A.
    van Vledder, M. G.
    van Damme-van Engel, S.
    Ambagtsheer, G.
    IJzermans, J. N. M.
    de Bruin, R. W. F.
    SCIENTIFIC REPORTS, 2019, 9 (1)